Corona Remedies IPO: Timeline, GMP, Financials, Risks & Full Review
Corona Remedies IPO opens Dec 8–10. Explore GMP trends, financials, strengths, risks, valuations, and complete IPO details in this investor-focused review.
Read FullArchive of all the blogs posted
Showing 12 articles this page
Corona Remedies IPO opens Dec 8–10. Explore GMP trends, financials, strengths, risks, valuations, and complete IPO details in this investor-focused review.
Read Full
Aequs IPO opens Dec 3–5 with strong aerospace tailwinds. Get a clear breakdown of price band, GMP, financials, use of proceeds, strengths, risks & long-term outlook.
Read Full
Meesho’s much-awaited IPO is here. Dive into its financials, valuations, GMP movement, category strengths, and the critical risks every investor should know before applying.
Read Full
Groww IPO 2025 (₹95–₹100). Find out all you need to know about the price band, timeline, business model, financials, and whether it’s worth subscribing.
Read Full
Lenskart IPO opens Oct 31, 2025. Read key financials, valuation, risks, and verdict before you invest. A neutral, data-backed review for investors.
Read Full
SEBI has barred mutual funds from investing in pre-IPO shares. Here’s why the decision matters, why fund houses oppose it, and what a middle path could look like.
Read Full
India’s top 55 IPOs in FY26 raised ₹64,920 crore. Discover how the biggest 15 IPOs performed - subscriptions, returns, and key investment lessons.
Read Full
LG Electronics India IPO (₹1,080–₹1,140). 100% OFS, lot 13. Snapshot, timeline, fundamentals, peer comparison, SWOT, GMP & FAQs - an interesting read.
Read Full
Tata Capital IPO, the largest IPO of 2025. Price band ₹310–₹326, lot 46. Snapshot of dates, fundamentals, valuation, SWOT & GMP - find out!
Read Full
Urban Company IPO opens 10–12 Sept 2025 at ₹98–₹103. See lot size (145 shares), issue split, timeline, key financials, valuation, SWOT & FAQs.
Read Full
Understand the NSDL IPO in detail – company overview, financials, valuation, risks, and should you invest. A must-read for retail & HNI investors.
Read Full
Explore IPO performance trends in India from FY20–FY25. See why promoter-backed IPOs outperformed PE-backed ones on listing gains and long-term returns.
Read Full